Efficacy of Ceftiofur Crystalline Free Acid Administered in the Posterior Aspect of the ear for Treatment of Bovine Respiratory Disease when a Retreatment Moratorium is Imposed

Authors

  • B. Hibbard Food Animal Development, Pharmacia Animal Health, Kalamazoo, MI 49001
  • E. J. Robb Food Animal Development, Pharmacia Animal Health, Kalamazoo, MI 49001
  • J. A. Meyer Food Animal Development, Pharmacia Animal Health, Kalamazoo, MI 49001
  • W. L. Bryson Food Animal Development, Pharmacia Animal Health, Kalamazoo, MI 49001
  • K. J. Dame Food Animal Development, Pharmacia Animal Health, Kalamazoo, MI 49001
  • M. J. Lucas Food Animal Development, Pharmacia Animal Health, Kalamazoo, MI 49001
  • D. T. Bechtol AgriResearch Center, Canyon, TX 79015
  • E. G. Johnson Johnson Research, Parma, ID 83660
  • M. I. Wray Wray & Associates

DOI:

https://doi.org/10.21423/aabppro20035291

Keywords:

cure rates, therapy, ceftiofur crystalline free acid sterile suspension, CCFA-SS, bovine respiratory disease, retreatment

Abstract

The objective of this three-location study was to evaluate the initial and durable cure rates, and to determine the duration of therapy, for ceftiofur crystalline free acid sterile suspension (CCFA-SS) for treatment of bovine respiratory disease (BRD) when a 3, 5 or 7-day retreatment moratorium was imposed. This study tested the hypothesis that retreatment during the period of effective plasma concentrations of ceftiofur may not improve treatment success rates.

Downloads

Published

2003-09-18

Issue

Section

Research Summaries - Beef

Most read articles by the same author(s)